Minimally Invasive Prostate Cancer Surgery Market in North America & Europe will reach USD 24.9 Billion By 2016

VN:F [1.9.22_1171]
Rating: 4.0/5 (2 votes cast)

Albany NY (February 19, 2013) (CULRAV.ORG) -

According to Transparency Market Research (www.transparencymarketresearch.com)North America & Europe Minimally Invasive Prostate Cancer Surgery Market (2011 – 2016) the prostate cancer minimally invasive surgical device market in North America Transparency Market Researchand Europe is estimated to be $14.2 billion in 2011 and expected to reach $24.9 billion in 2016 at a CAGR of 11.9% over the period 2011 to 2016. The monitoring and visualization segment is the leading market contributor with a share of around 38% in 2011.

 

Browse full report at http://www.transparencymarketresearch.com/prostat-cancer-minimal-invasive-surgery-market.html

Prostate cancer is the second most leading cause of cancer associated mortality among men after lung cancer. In 2010, more than 1.9 million people have been diagnosed with the prostate cancer across the world. African Americans and whites are most affected with this disease. Old age, heredity, lifestyle aspects such as smoking and diet rich in red meat are the major factors increasing the risk of getting affected with the disease.

 

The estimated market of North America & Europe minimally invasive prostate cancer surgical device is USD 14.2 billion in 2011 and expected to realize a growth of 11.9% over the period of 2011 to 2016. U.S. is the leading market of minimally invasive prostate cancer surgical devices with an estimated share of around 56% (USD 8 Billion) in 2011and expected to become USD 13 billion (52%) in 2016. Germany is the second high growth market and is the leading market in Europe. It has the estimated market share of about 11% in 2011and is expected to reach USD 3 billion in 2016.

 

Digital Rectal Exam (DRE), Prostate Biopsy, Prostate Specific Antigen (PSA) blood test, bone scan, ultrasound, CT scan, MRI, lymph node biopsy and ProstaScint monoclonal antibody scanare some of the methods used to diagnose the prostate cancer. Among the surgical techniques, minimally invasive have become quite popular in the last decade.Laparoscopy, cryosurgery, brachytherapy and robotic surgery are the commonly practices surgical techniques while performing minimally invasive surgeries for the treatment of prostate cancer. Laparoscopy has the comparative high adoption rate among the surgeons, while surgical robot has significantly emerged as the top preference in past decade. In spite of high cost of robots (close to USD 1.5 million), their adoption has considerably increased due to better precision, dexterity, improved surgery control, reduced risk of surgical side effects such as impotency, shorter hospital stay, lesser pain, quicker recovery.

 

Prostate cancer minimally invasive surgery market in North America & Europe is quiteconsolidated. Global players like Ethicon Endo Surgery, Covidien, Intuitive Surgical, Boston Scientific Corporation and Carefusion Corporation holds over 4/5th of the market in 2010. Ethicon Endo Surgery is the market leader with control over 1/3rdof market, followed by Covidien. Further, Intuitive Surgical, Boston Scientific Corporation, Carefusion Corporation and Olympus are closely positioned with shares between 13% and 5%.

Related Reports:

http://www.transparencymarketresearch.com/cardiovascular-monitoring-diagnostic-devices-market.html

http://www.transparencymarketresearch.com/coronary-stents-market.html

Scope and Overview

The objective of the study on “Minimally Invasive Prostate cancer Surgery Market in North America and Europe” is to gain detailed market insights for minimally invasive surgical techniques and devices used to treat prostate cancer in developed economies where the reported cancer incidence is very high. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share.The report also covers the strategies followed by “Minimally Invasive Prostate cancer Surgery Market in North America and Europe” players.

 

Segmentation & Analysis

The report segments and analyzes the “Minimally Invasive Prostate Cancer Surgery Market in North America and Europe” on the basis of following sub-categories:

 

  • Geographic Markets
    • North America
    • European

 

This section provides in-depth analysis of “Minimally Invasive Prostate cancer Surgery Market in North America and Europe” that includes market size and growth forecast for each geography, driving factors, challenges and opportunities prevailing in the particular geography.

 

  • Devices Market
    • Surgical Devices
      • Hand Instruments
      • Powered Surgical Instruments
        • Electrosurgical and Auxiliary Equipment
        • Lasers
  • Monitoring and Visualization Systems
    • Cameras & Video Support
    • Endoscopic Trocars with Optical View
  • Endosurgical Equipment
    • Endoscope
    • Surgical Robotics

This section provides in-depth analysis of minimally invasive surgical devices market size and growth forecast for each sub segment, driving factors and challenges prevailing in the overall and at the micro market levels, and opportunities and future outlook for all the levels.

 

  • Surgical Techniques
    • Laparoscopic Surgery
    • Brachytherapy
    • Cryosurgery
    • Robotic surgery

This section provides in-depth analysis of minimally invasive surgical techniques market size and growth forecast for each sub segment and opportunities and future outlook for all the levels.

 

  • Competition Analysis& Future Trends

 

This section analyses the competition prevailing at each micro level and the detailed future outlook for the each sub segment of the market.

 

  • Company Profiles of Top Ten Players

 

This section provides brief overview of top market players in the “Minimally Invasive Prostate cancer Surgery Market in North America and Europe”. The profile of each company includes brief overview, key financials, product & services, recent developments and key strategies adopted by the player.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports thrive to provide clients to serve their overall research requirement.

 

Contact

Ms. Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

VN:F [1.9.22_1171]
Rating: 4.0/5 (2 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)
Minimally Invasive Prostate Cancer Surgery Market in North America & Europe will reach USD 24.9 Billion By 2016, 4.0 out of 5 based on 2 ratings


Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Author: Transparency Market Research@ Transparency Market Research

Comments are closed.